SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-030852
Filing Date
2024-07-02
Accepted
2024-07-02 16:45:42
Documents
4
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1719953134.html 4  
1 FORM 4 wk-form4_1719953134.xml 4 3776
2 EX-24 exhibit24ricepoa.htm EX-24 4373
3 exhibit24ricepoa001.jpg GRAPHIC 247294
4 exhibit24ricepoa002.jpg GRAPHIC 35713
  Complete submission text file 0001628280-24-030852.txt   399855
Mailing Address C/O UNITEDHEALTH GROUP 9900 BREN ROAD EAST, MN008-T502 MINNETONKA MN 55343
Business Address 952-936-1300
MONTGOMERY RICE VALERIE MD (Reporting) CIK: 0001714561 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39587 | Film No.: 241096372

Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Issuer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)